Secondary Logo

Journal Logo

Institutional members access full text with Ovid®


Kathren, Ronald L.*; Burklin, Richard K.

doi: 10.1097/01.HP.0000288043.94908.1f

Although human experience with uranium spans more than 200 years, the LD50 for acute intake in humans has not been well established. Large acute doses of uranium can produce death from chemical toxicity in rats, guinea pigs, and other small experimental animals, with variation in sensitivity among species. However, there has never been a death attributable to uranium poisoning in humans, and humans seem to be less sensitive to both acute and chronic toxic effects of uranium than other mammalian species studied. Highly relevant data on uranium toxicity in humans are available from the experience of persons administered large doses of uranium for therapy of diabetes and from acute accidental inhalation intakes. Although the data on which to establish oral and inhalation acute LD50 for uranium in humans are sparse, they are adequate to conclude that the LD50 for oral intake of soluble uranium compounds exceeds several grams of uranium and is at least 1.0 g for inhalation intakes. For intakes of uranium compounds of lesser solubility, acute LD50 values are likely to be significantly greater. It is suggested that 5 g be provisionally considered the acute oral LD50 for uranium in humans. For inhalation intakes of soluble compounds of uranium, 1.0 g of uranium is proposed as the provisional acute inhalation LD50.

* Washington State University at Tri-Cities, Richland, WA 99357; Areva Corporation, Richland, WA 99357.

For correspondence contact: Ronald L. Kathren, 137 Spring, Richland, WA 99354-1651, or email at

(Manuscript accepted 20 August 2007)

©2008Health Physics Society